Zobrazeno 1 - 10
of 113
pro vyhledávání: '"Meng Xu Welliver"'
Autor:
Steven H Lin, Heather Y Lin, Vivek Verma, Meng Xu-Welliver, Peter F Thall, Luyang Yao, Peter Y Kim, Dan S Gombos, Jitesh D Kawedia, Ritsuko Komaki, Daniel R Gomez, Quynh-Nhu Nguyen, Michael S O'Reilly, Charles Lu, Frank V Fossella, Ferdinandos Skoulidis, Jianjun Zhang, Anne S Tsao, John V Heymach, George R Blumenschein
Publikováno v:
Cancer Treatment and Research Communications, Vol 30, Iss , Pp 100514- (2022)
ABSTRACT: OBJECTIVE: This phase I trial (NCT01912625) evaluated the safety and pharmacokinetics of definitive concurrent chemoradiotherapy (cCRT) and the radiosensitizer trametinib (MEK1/2 inhibitor) for KRAS-mutated nonmetastatic non-small cell lung
Externí odkaz:
https://doaj.org/article/e18ec14896714573b1d9b08755f7ce93
Autor:
Nikhil T. Sebastian, Rohit Raj, Rahul Prasad, Christian Barney, Jeremy Brownstein, John Grecula, Karl Haglund, Meng Xu-Welliver, Terence M. Williams, Jose G. Bazan
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
ObjectivesNeutrophil–lymphocyte ratio (NLR) has been associated with mortality in non-small cell lung cancer (NSCLC), but its association with recurrence in locally advanced NSCLC (LA-NSCLC), specifically, is less established. We hypothesized pre-
Externí odkaz:
https://doaj.org/article/1ec357becd8f438db4a0fbf101be8d95
Autor:
Eric D Miller, James L Fisher, Karl E Haglund, John C Grecula, Meng Xu-Welliver, Erin M Bertino, Kai He, Peter G Shields, David P Carbone, Terence M Williams, Gregory A Otterson, Jose G Bazan
Publikováno v:
Radiation Oncology, Vol 13, Iss 1, Pp 1-10 (2018)
Abstract Background To compare patterns of care for elderly patients versus non-elderly patients with non-surgically treated stage III non-small cell lung cancer (NSCLC) using the National Cancer Database (NCDB). We hypothesize that elderly patients
Externí odkaz:
https://doaj.org/article/f2a836765e9b414ba53a6bf53cdae1cf
Autor:
Amanda B. Kagan, Nicole M. Anders, Avelina Hemingway, Eudocia Q. Lee, Kevin R. Kelly, Hans C. Lee, Meng Xu‐Welliver, Richard Piekarz, Michelle A. Rudek
Publikováno v:
Biomedical Chromatography. 36
Navtemadlin is an orally bioavailable small molecule that blocks the protein-protein interaction between murine double minute 2 protein (MDM2) and the tumor suppressor protein p53, leading to p53-mediated cell cycle arrest and apoptosis. It is being
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3cfe269ea4228e56dc584b880ff7d4f2
https://doi.org/10.1002/bmc.5467
https://doi.org/10.1002/bmc.5467
Autor:
Ming Lu, Yongmeng Li, Renchang Zhao, Meng Xu-Welliver, Chuanle Cheng, Stéphane Renaud, Zitong Feng, Rui Dong, Hui Tian, Jingyi Han, Jinghui Liang, Jin Jiang
Publikováno v:
Transl Lung Cancer Res
Background Lung cancer is a malignant tumor with the highest morbidity and mortality rates worldwide, of which lung adenocarcinoma (LUAD) is the most common subtype. Overall, current treatments of LUAD are not satisfactory; therefore, novel targets n
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::06837dc390f9edfc8030b7f4aa1865d0
https://doi.org/10.21037/tlcr-21-299
https://doi.org/10.21037/tlcr-21-299
Autor:
Samer Salamekh, Yi Rong, Ahmet S Ayan, Xiaokui Mo, Terence M Williams, Nina A Mayr, John C Grecula, Arnab Chakravarti, Meng Xu-Welliver
Publikováno v:
PLoS ONE, Vol 11, Iss 4, p e0153245 (2016)
PURPOSE:Analyze inter-fraction volumetric changes of lung tumors treated with stereotactic body radiation therapy (SBRT) and determine if the volume changes during treatment can be predicted and thus considered in treatment planning. METHODS AND MATE
Externí odkaz:
https://doaj.org/article/9317806ac71a4345908b008ce47cef8a
Autor:
Walter G. Hanel, Catherine G. Chung, Nikol Mladkova, Michael Weldon, Basem William, Meng Xu-Welliver
Publikováno v:
Practical Guides in Radiation Oncology ISBN: 9783031067051
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::814b9eeb9db1641517a1149db13a4b6f
https://doi.org/10.1007/978-3-031-06706-8_16
https://doi.org/10.1007/978-3-031-06706-8_16
Autor:
Kelly H Tyler, Brad M Haverkos, Justin eHastings, Eileen eHu, Ramez ePhilips, Alejandro A Gru, Meng Xu Welliver, Anjali eMishra, Henry K Wong, Pierluigi ePorcu
Publikováno v:
Frontiers in Oncology, Vol 5 (2015)
The clinical benefit of a multidisciplinary clinic practice model has been well described in a variety of medical specialties and cancer types. It proves particularly valuable when an integrated team is needed to optimally manage patients with rare o
Externí odkaz:
https://doaj.org/article/3d55713845664aaab175817deb36ff30
Publikováno v:
PLoS ONE, Vol 10, Iss 7, p e0131945 (2015)
Stereotactic body radiotherapy (SBRT) is being increasingly used for the treatment of patients with lung cancer or lung metastasis who are medically unfit to undergo resection. In order to improve accuracy and confidence in targeting tumors, many cen
Externí odkaz:
https://doaj.org/article/d3ecbf3748c74ced8f38e39a916d5abe
Publikováno v:
PLoS ONE, Vol 10, Iss 4, p e0126222 (2015)
Whole brain radiotherapy (WBRT) is a vital tool in radiation oncology and beyond, but it can result in adverse health effects such as neurocognitive decline. Hippocampal Avoidance WBRT (HA-WBRT) is a strategy that aims to mitigate the neuro-cognitive
Externí odkaz:
https://doaj.org/article/f0eae7aa555a41ff9e02c7b2c1356c4b